Drug Database
ME

methylene blue (Lumeblue / methylene blue MMX)

✓ Approved

Cosmo Pharmaceuticals · 小分子 · 小分子

什么是 methylene blue?

methylene blue 是一种小分子,由Cosmo Pharmaceuticals研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Lumeblue, methylene blue MMX
公司Cosmo Pharmaceuticals
药物类别小分子
给药途径Oral (PO)
状态Approved

治疗适应症

methylene blue 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersGastrointestinal mucosal necrosis✓ Approved

相关研究文献

PubMedWorld journal of surgery2026-11-17

Sentinel Lymph Node Biopsy in Post-Neoadjuvant Chemotherapy Breast Cancer Patients Using a Combination of Fluorescein and Blue Dye Versus Blue Dye Alone: Randomized Pilot Feasibility Trial.

Rajendar Byshetty B, Vishnoi Jeewan Ram JR, Sharma Nivedita N, Poonia Dharma Ram DR et al.

Sentinel lymph node biopsy is standard for staging clinically node-negative (cN0) breast cancer, but the dual tracer gold-standard radioisotope-blue dye technique is unavailable in resource-limited settings. Fluorescein, an inexpensive, safe, visible-light tracer, has no randomized data after neoadjuvant chemotherapy (NACT). We compared fluorescein-methylene blue with methylene blue alone for sentinel lymph node biopsy in post-NACT cN0 patients and, secondarily, assessed the accuracy of axillary ultrasound. In this randomized pilot feasibility trial, post-NACT cN0 breast cancer patients were randomized 1:1 to fluorescein-methylene blue (FlaB) or methylene blue alone after dye allergy testing. All patients underwent completion axillary lymph node dissection as the reference standard. Identification rate and false-negative rate were estimated with 95% confidence intervals. Of 136 patients who received NACT, 62 (45.6%) had a clinical complete nodal response and were recruited; 2 (3.2%) were excluded for methylene blue allergy, leaving 30 randomized per group, with all 60 completing the protocol. IR: 93.3% (28/30; 95% CI, 78.7-98.1) with FlaB versus 83.3% (25/30; 95% CI, 66.4-92.7) with methylene blue alone (difference, 10.0 percentage points; p = 0.23). FNR: 11.1% (2/18; 95% CI, 3.1-32.8) versus 12.5% (2/16; 95% CI, 3.5-36.0; p = 0.87). On secondary analysis, axillary ultrasound was normal in 30 of 62 patients (48.4%) and suspicious in 32 (51.6%); against final pathology, its sensitivity was 80.6%, and its negative predictive value was 76.7%; 7 of the 36 node-positive patients (19.4%) had a sonographically normal axilla. No dye-related adverse events occurred. FlaB achieved an identification rate above the 90% benchmark and a false-negative rate comparable to radioisotope-based dual-tracer series. Axillary ultrasound did not reliably exclude residual nodal disease (negative predictive value 76.7%) and cannot replace pathological nodal staging after NACT. Fluorescein-methylene blue is a safe, radioisotope-free dual-tracer strategy for SLNB in resource-limited settings.

PMID 43040966
阅读全文 →
PubMedACS applied bio materials2026-11-17

β-Cyclodextrin-Modified Methylene Blue-Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy.

Abouhagger Adei A, Milaknytė Laura L, de Melo Wanessa W, Stirkė Arūnas A et al.

Antimicrobial photodynamic therapy offers a route to bacterial inactivation that does not depend on conventional resistance mechanisms, and methylene blue (MB) is among the most established photosensitizers. Its efficiency, however, is governed by aggregation state: only monomeric MB generates singlet oxygen efficiently, while the dimers that form within negatively charged carriers such as alginate are photodynamically inactive. Here, we report a droplet-microfluidic platform for fabricating monodisperse MB-loaded calcium alginate microgels and exploit β-cyclodextrin (β-CD) co-encapsulation to control the monomer fraction of the released dye. Internal-gelation flow-focusing produced uniform microgels (∼132 µm; coefficient of variation 2.1%), within which increasing β-CD content progressively raised the monomeric fraction of the released MB, as quantified by the A664/A610 absorbance ratio. Photosensitized ROS generation under 630 nm irradiation, measured with 1,3-diphenylisobenzofuran in a medium that preserves MB aggregation, was 1.9-fold higher for the β-cyclodextrin formulation, and the microgels produced clear, light-dependent killing of Staphylococcus aureus and Escherichia coli. β-Cyclodextrin co-encapsulation significantly enhanced bactericidal activity against S. aureus (p < 0.01), with the same trend in E. coli. By making photosensitizer monomer fraction, dose, and carrier geometry separately measurable and tunable within a single monodisperse platform, this work provides a route toward the rational optimization of photodynamic antibacterial microgels.

PMID 43042809
阅读全文 →
PubMedEnvironmental science and pollution research international2026-11-17

Eco-conscious synthesis of a starch-based magnetic hydrogel for effective methylene blue decontamination in wastewater treatment.

Alviz-Meza Anibal A, Álvarez-Torrellas Silvia S, Huaccallo-Aguilar Ysabel Y, Carranza-Oropeza María Verónica MV et al.

Native Peruvian potato starch was valorised to produce a magnetic poly(acrylic acid) hydrogel via radical copolymerisation followed by in situ co-precipitation with Fe3O4 nanoparticles, and it was tested for methylene blue (MB) removal from different effluents. FTIR, XRD, SEM-EDS, and VSM techniques confirmed acrylic grafting and homogeneous magnetite anchoring, providing magnetic separability. Thus, the hydrogel-based adsorbent showed pH-responsive swelling capacity (up to 352.1 g/g) and a slightly alkaline pHPZC value of 7.92. A maximum MB removal of 96% and an equilibrium adsorption capacity of 1000 mg/g were achieved within 3 h. The equilibrium adsorption data were best fitted to the Langmuir model (qmax = 1148.3 mg/g), and the adsorption process could be considered spontaneous and exothermic (ΔH° = - 17.7 kJ/mol). Removal remained above 90% after five consecutive adsorption-desorption cycles, with low %Fe leaching (0.51%) after regeneration. In adsorption tests using surface water and WWTP effluent, MB removal decreased to 38 and 30%, respectively. The high concentrations of divalent cations, TDS, and TOC in the effluents could explain this behaviour, in accordance with the conducted DFT/NBO theoretical analysis. Treated effluents showed no significant ecotoxicity in Vibrio fischeri tests. The elucidated adsorption mechanism mainly involved electrostatic interactions, hydrogen bonding, n-π interactions, and pore diffusion of MB molecules within the hydrogel structure. Also, the operating cost for MB removal was only 0.99 €/m3. Thus, the synthesised material was established as a promising bio-based, reusable adsorbent for alkaline, low-NOM concentration dye effluents, while its application to more complex matrices requires further optimisation.

PMID 43040123
阅读全文 →
PubMedOrganic & biomolecular chemistry2026-11-17

Design, synthesis and photophysical properties of a meso-α methylene-bridged bisBODIPY.

Feng Yuan-Mei YM, Wang Long L, Zhang Ke-Feng KF

A new type of meso-α methylene-bridged bisBODIPY was developed through a homo-SNAr type reaction. The resultant bisBODIPY was fully characterized, displaying high molar extinction coefficients and large Stokes shifts. Furthermore, this structurally unprecedented bisBODIPY exhibited a singlet oxygen quantum yield of 0.28 in toluene, which may find potential application as a heavy-atom-free photosensitizer.

PMID 43042563
阅读全文 →
PubMedDermatology online journal2026-11-17

Blue rubber bleb nevus syndrome.

Zouine Ikram I, Mhaimer Soukaina S, Aitoussous Sara S, El Halla Hanane H et al.

PMID 43040824
阅读全文 →
PubMedInternational journal of nanomedicine2026-11-17

Copper-Doped Carbon Quantum Dots with Near-Infrared Photothermal and Photodynamic Performance for in vitro Dual-Modal Phototherapeutic Eradication of Embryonal Carcinoma Cells.

Mahani Mohamad M, Montazer Leila L

The clinical efficacy of conventional photodynamic therapy (PDT) remains constrained by limited light penetration in deep tissue and suboptimal ROS yields of traditional photosensitizers. This study aimed to develop biocompatible copper-doped carbon quantum dots (NIR-CQDs) exhibiting near-infrared (NIR) absorption to achieve dual photothermal and photodynamic ablation of malignant cells within the biological transparency window. NIR-CQDs were synthesized via a facile, one-step hydrothermal method. The nanostructures were characterized by UV-Vis-NIR absorption and fluorescence spectroscopy. Photothermal performance and thermal stability were evaluated under continuous 808 nm laser irradiation. ROS quantum yield was quantified using 1,3-diphenylisobenzofuran (DPBF) as a chemical probe against methylene blue. Light-activated in vitro cytotoxicity were systematically assessed in human NCCIT embryonal carcinoma cells. A reactive oxygen species (ROS) quenching assay utilizing reduced glutathione (GSH) was employed to evaluate the relative contributions of localized hyperthermia and oxidative pathways. The synthesized NIR-CQDs exhibited an average hydrodynamic size of ~5 nm with NIR absorption extending near 780 nm. The NIR-CQDs demonstrated ROS generation ([Formula: see text] = 6.96%), alongside photothermal conversion that elevated aqueous temperatures to 62 °C under 808 nm illumination, displaying stable photothermal cycling. In vitro evaluations demonstrated negligible dark cytotoxicity in NCCIT cells across tested concentrations. Upon 808 nm NIR irradiation, NIR-CQDs mediated substantial phototoxicity, reducing cancer cell viability to ~35% (p < 0.001). Pre-treatment with GSH partially restored cell viability to ~55% (p < 0.001 vs. laser alone), indicating a significant contribution from ROS-mediated photodynamic effects alongside photothermal hyperthermia. A carbon-based NIR-CQD nanoplatform was developed, integrating ROS generation with NIR-driven photothermal conversion. The combination of photodynamic and photothermal effects provides an effective approach for cell killing in vitro, highlighting the potential of these NIR-CQDs for NIR-activated cancer phototherapy.

PMID 43042332
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多methylene blue